The incidence of Pneumocystis jirovecii pneumonia is not higher in patients receiving dose-dense therapy with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine, and prednisolone and adequate Pneumocystis jirovecii pneumonia prophylaxis

被引：3
|
作者：
Isidori, Alessandro [1 ]
Merli, Francesco [2 ]
Angrilli, Francesco [3 ]
Ferrara, Felicetto [4 ]
Alesiani, Francesco [5 ]
Visani, Giuseppe [1 ]
机构：
[1] San Salvatore Hosp, Hematol & Hematopoiet Stem Cell Transplant Ctr, I-61100 Pesaro, Italy
[2] Arcispedale, Dept Oncohematol, Reggio Emilia, Italy
[3] Santo Spirito Hosp, Dept Hematol, Pescara, Italy
[4] Cardarelli Hosp, Dept Hematol, Naples, Italy
[5] Bartolomeo Eustacchio Hosp, Dept Oncohematol, San Severino Marc, Italy
来源：
LEUKEMIA & LYMPHOMA | 2011年 / 52卷 / 01期
关键词：
D O I：
10.3109/10428194.2010.525726
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：148 / 149
页数：2
相关论文
共 14 条
  • [1] Primary Prophylaxis for Pneumocystis jirovecii Pneumonia in Patients Receiving Rituximab
    Park, Jun Won
    Curtis, Jeffrey R.
    Jun, Kang Il
    Kim, Tae Min
    Heo, Dae Seog
    Ha, Jongwon
    Suh, Kyung-Suk
    Lee, Kwang-Woong
    Lee, Hajeong
    Yang, Jaeseok
    Kim, Min Jung
    Choi, Yunhee
    Lee, Eun Bong
    CHEST, 2022, 161 (05) : 1201 - 1210
  • [2] High incidence of Pneumocystis jirovecii pneumonia in patients receiving biweekly rituximab and cyclophosphamide, adriamycin, vincristine, and prednisone
    Kamel, Sarah
    O'Connor, Shaun
    Lee, Newton
    Filshie, Robin
    Nandurkar, Harshal
    Tam, Constantine S.
    LEUKEMIA & LYMPHOMA, 2010, 51 (05) : 797 - 801
  • [3] Pneumocystis jirovecii Pneumonia in Three Patients With Breast Cancer Receiving Neoadjuvant Dose-Dense Chemotherapy
    Shiiba, Ritsuya
    Himeji, Daisuke
    Matsumoto, Ryoichi
    Tanaka, Gen-ichi
    Otomo, Naoki
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [4] Pneumocystis jirovecii Pneumonia in a Patient with Breast Cancer Receiving Neoadjuvant Dose-dense Chemotherapy
    Watanabe, Hirofumi
    Kitahara, Yoshihiro
    Murakami, Yurina
    Nihashi, Fumiya
    Matsushima, Sayomi
    Eifuku, Tatsuru
    Uto, Tomohiro
    Sato, Jun
    Imokawa, Shiro
    Suda, Takafumi
    INTERNAL MEDICINE, 2020, 59 (07) : 987 - 990
  • [5] Incidence of Pneumocystis jirovecii pneumonia (PJP) in patients receiving BTK inhibitors who did not receive PJP prophylaxis
    Davis, James A.
    Graham, Anastasia
    Hendrickson, Lindsey
    Hess, Brian
    Gaffney, Kelly
    LEUKEMIA & LYMPHOMA, 2022, 63 (08) : 2016 - 2018
  • [6] Risk-Benefit Analysis of Primary Prophylaxis Against Pneumocystis Jirovecii Pneumonia in Patients With Rheumatic Diseases Receiving Rituximab
    Park, Jun Won
    Curtis, Jeffrey R.
    Choi, Se Rim
    Kim, Min Jung
    Ha, You-Jung
    Kang, Eun Ha
    Lee, Yun Jong
    Lee, Eun Bong
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 (11) : 2036 - 2044
  • [7] Pneumocystis jirovecii Pneumonia Prophylaxis in non-HIV pulmonary patients on chronic corticosteroid therapy: make a virtue of necessity?
    Kolilekas, Likurgos
    Papiris, Spyros A.
    Bouros, Demosthenes
    PNEUMON, 2015, 28 (01) : 28 - 30
  • [8] REDUCED DOSE OF NON-PEGYLATED LIPOSOMAL DOXORUBICIN WITH CYCLOPHOSPHAMIDE, VINCRISTINE AND PREDNISONE RITUXIMAB FOR PREVIOUSLY UNTREATED ELDERLY PATIENTS WITH AGGRESSIVE LYMPHOMA NON SUITABLES FOR STANDARD CHEMOTHERAPY
    Gimeno, E.
    Alvarez, A.
    Pedro, C.
    Abella, E.
    Gomez, M.
    Comin, J.
    Sanchez, B.
    Gimenez, T.
    Besses, C.
    Salar, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 502 - 502
  • [9] Reduced dose of non-pegylated liposomal doxorubicin with cyclophosphamide, vincristine and prednisone ± rituximab for previously untreated elderly patients with aggressive lymphoma non suitables for standard chemotherapy
    Gimeno, E.
    Alvarez, A.
    Pedro, C.
    Abella, E.
    Gomez, M.
    Comin, J.
    Sanchez, B.
    Besses, C.
    Salar, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 218 - 218
  • [10] Role of Pneumocystis Jirovecii Pneumonia Prophylaxis with TrimethoprimSulfamethoxazole Among Patients with Autoimmune Inflammatory Diseases Receiving High-Dose Glucocorticoids: A Systematic Review and Meta-Analysis
    Vassilopoulos, Athanasios
    Vassilopoulos, Stephanos
    Shehadeh, Fadi
    Kalligeros, Markos
    Mylonakis, Eleftherios
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 398 - 400
12